Central Pathology Review

Grant Details

Grantee Name:
 Dr. Giuseppe Viale
Organization:
 International Breast Cancer Study Group
Country: European (Located in Switzerland)

Project Name:
 Central Pathology Review of FFPE tumor blocks within the POSITIVE study
Funding Year:
 2020
Project period: 5 years

Central Pathology Review of FFPE tumor blocks within the POSITIVE study

The primary goal of the POSITIVE trial is to determine if a two-year interruption of endocrine therapy results in a significantly higher breast cancer event rate in comparison to a historically estimated control rate if no interruption occurred. Samples have been collected from 90 % of the patients enrolled in the POSITIVE clinical trial and funding is required for processing and analysis.

icon-social-share-linkedin Created with Sketch.
icon-play Created with Sketch.
icon-download Created with Sketch.